Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Apply
TCR-Engineered T Cells
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step